BerandaBBN • SWX
add
Bellevue Group AG
Tutup sebelumnya
CHF 14,75
Rentang hari
CHF 14,50 - CHF 14,80
Rentang tahun
CHF 11,05 - CHF 24,30
Kapitalisasi pasar
195,19 jt CHF
Volume Rata-Rata
9,95 rb
Rasio P/E
13,08
Hasil dividen
7,93%
Bursa utama
SWX
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
(CHF) | Jun 2024info | Perubahan Y/Y |
---|---|---|
Pendapatan | 18,41 jt | -11,31% |
Biaya operasional | 13,73 jt | -10,56% |
Laba bersih | 3,72 jt | -7,22% |
Margin laba bersih | 20,18 | 4,61% |
Penghasilan per saham | — | — |
EBITDA | — | — |
Tarif pajak efektif | 17,26% | — |
Neraca
Total aset
Total liabilitas
(CHF) | Jun 2024info | Perubahan Y/Y |
---|---|---|
Investasi tunai jangka pdk | 30,49 jt | 100,63% |
Total aset | 138,75 jt | -4,69% |
Total liabilitas | 22,05 jt | -24,81% |
Total ekuitas | 116,70 jt | — |
Saham yang beredar | 13,20 jt | — |
Harga terhadap nilai buku | 1,67 | — |
Tingkat pengembalian aset | 10,71% | — |
Tingkat pengembalian modal | — | — |
Arus Kas
Perubahan kas bersih
(CHF) | Jun 2024info | Perubahan Y/Y |
---|---|---|
Laba bersih | 3,72 jt | -7,22% |
Kas dari operasi | 3,65 jt | 137,31% |
Kas dari investasi | — | — |
Kas dari pembiayaan | -8,10 jt | 45,85% |
Perubahan kas bersih | -4,17 jt | 83,13% |
Arus kas bebas | — | — |
Tentang
Bellevue Group AG, headquartered in Zurich, is a listed investment management corporation from Switzerland. Bellevue Group consists of the subsidiaries Bellevue Asset Management, Bellevue Private Markets and StarCapital. It has 9,6 billion Swiss francs Assets Under Management Around 80% of clients assets are in healthcare investments. Bellevue Group is also active in alternative investments and private equity, including co-investments in private domestic small and medium-sized enterprises. In this business area, client assets under management were 1.0 billion francs as of mid-2021.
Bellevue Group is among the largest investors in the health care segment worldwide. It has subsidiaries in Germany, UK and USA, and is focusing on platform companies with products in phase two trials or later who preferably develop technologies that can be applied in multiple ways. One of the Bellevue Asset Management teams manages the BB Biotech investment company. The former investment company BB Medtech, which was converted into an equity fund at the end of September 2009, is also managed by Bellevue Asset Management. Wikipedia
CEO
Didirikan
1993
Situs
Karyawan
88